Issue 6, 2018

Cyclotriphosphazene core-based dendrimers for biomedical applications: an update on recent advances

Abstract

This review is focused on the recent use of cyclotriphosphazene-based dendrimers in biomedicine. Since its synthesis for the first time in 1834, cyclotriphosphazene has been an important compound of phosphorus chemistry as a scaffold, and a large number of cyclotriphosphazene derivatives have been synthesized and applied in various fields such as biology, catalysis, fluorescence, nanomaterials, etc. Today, one of the most important uses concerns its biomedical applications. In this review, the recent developments (since 2012) of cyclotriphosphazene for major pharmaceutical applications are highlighted and analyzed.

Graphical abstract: Cyclotriphosphazene core-based dendrimers for biomedical applications: an update on recent advances

Article information

Article type
Review Article
Submitted
28 Nov 2017
Accepted
11 Jan 2018
First published
11 Jan 2018

J. Mater. Chem. B, 2018,6, 884-895

Cyclotriphosphazene core-based dendrimers for biomedical applications: an update on recent advances

L. Wang, Y. Yang, X. Shi, S. Mignani, A. Caminade and J. Majoral, J. Mater. Chem. B, 2018, 6, 884 DOI: 10.1039/C7TB03081A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements